Common use of Commercial Diligence Clause in Contracts

Commercial Diligence. Pfizer will use Commercially Reasonable Efforts to Commercialize at least [**] in [**], where Pfizer or its designated Affiliates or sublicensees seek and receive Regulatory Approval for such [**]. Pfizer will have no other diligence obligations with respect to the Commercialization of Licensed Products except as otherwise set forth in this Agreement.

Appears in 3 contracts

Samples: License Agreement, License Agreement (Spark Therapeutics, Inc.), License Agreement (Spark Therapeutics, Inc.)

AutoNDA by SimpleDocs

Commercial Diligence. Pfizer will shall use Commercially Reasonable Efforts to Commercialize at least each Product [**] in which it receives Marketing Approval, provided that should Pfizer terminate this Agreement pursuant to Section 12.2(a) with respect to a Product in [**], where then Pfizer or its designated Affiliates or sublicensees seek and receive Regulatory Approval for shall use Commercially Reasonable Efforts to Commercialize such Product in [**]. Pfizer will have no other [*] diligence obligations with respect to the Commercialization of Licensed Products except as otherwise set forth in under this Agreement.

Appears in 1 contract

Samples: Collaboration and License Agreement (Sangamo Therapeutics, Inc)

Commercial Diligence. Pfizer will use its Commercially Reasonable Efforts to Commercialize at least a given Product [**] in [**], *] where Pfizer or its designated Affiliates or sublicensees seek and receive has received Regulatory Approval for such [**]Product in such indication. Except pursuant to the foregoing and Section 8.6.1, as applicable, Pfizer will have no other diligence obligations with respect to the Commercialization of Licensed Products except as otherwise set forth in under this Agreement.

Appears in 1 contract

Samples: License Agreement (Theravance Biopharma, Inc.)

AutoNDA by SimpleDocs

Commercial Diligence. Pfizer will shall use Commercially Reasonable Efforts to Commercialize at least each Product [**] in which it receives Marketing Approval, provided that should Pfizer terminate this Agreement pursuant to Section 12.2(a) with respect to a Product in [**], where then Pfizer or its designated Affiliates or sublicensees seek and receive Regulatory Approval for shall use Commercially Reasonable Efforts to Commercialize such Product in [**]. Pfizer will have no other [*] diligence obligations with respect to the Commercialization of Licensed Products except as otherwise set forth in under this Agreement.. 8.3

Appears in 1 contract

Samples: Collaboration and License Agreement (Sangamo Therapeutics, Inc)

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!